The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Share News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.00
Bid: 6.75
Ask: 7.25
Change: 0.00 (0.00%)
Spread: 0.50 (7.407%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 7.00
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Parity and Brave Bison expect to beat forecasts

Thu, 20th Jan 2022 10:58

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Parity Group PLC, up 15% at 7.75 pence, 12-month range 6p-14p. The data and technology-focused recruiter says it has "met or marginally exceeded" market forecasts for 2021 following refocus on core recruitment solutions capability. Revenue to be slightly ahead of GBP47.6 million target and anticipates modest adjusted earnings before interest, tax, depreciation and amortisation profit, instead of a small loss.

----------

Brave Bison Group PLC, up 13% at 1.8p, 12-month range 1.2p-2.1p. The social media and marketing firm expects 2021 results ahead of both market forecasts and the prior year after strong second half trading. Expects 2021 revenue of at least GBP21.3 million, versus GBP14.5 million in 2020, and pretax profit no less than GBP400,000 after loss of GBP2.3 million the year before. "We expect trading to remain strong as our customers respond positively to Brave Bison's new proposition that combines an owned digital media network with a suite of social and digital marketing services," says Executive Chair Oliver Green.

----------

AIM - LOSERS

----------

Ixico PLC, down 7.4% at 53.75p, 12-month range 48p-115p. Says client has confirmed it will close open-label extension study in Huntington's disease in May, which is expected to result in a GBP300,000 reduction in 2022 revenue. This means that, including the loss of expected revenue for the remaining 3-year period of the contract, the clinical research firm now has an order book totalling GBP12.6 million.

----------

Marlowe PLC, down 2.3% at 1,021.50p, 12-month range 570p-1,085p. The safety and regulatory compliance services and software firm agrees to buy Optima Health Group Ltd for GBP135 million. Plans GBP130 million share placing to fund the deal. Optima is a provider of technology-enabled Occupational Health services in the UK.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
22 May 2014 12:07

IXICO Wins Contracts For Huntington's Disease Clinical Trials

LONDON (Alliance News) - Brain health company IXICO PLC Thursday said it has won contracts for two separate clinical trials in Huntington's disease with "top 15" pharmaceutical companies, building on a third clinical study already underway on the disease. In a statement, IXICO said the two

Read more
16 Apr 2014 09:54

IXICO Awarded Development Contract By NHS England Initiative

LONDON (Alliance News) - IXICO PLC Wednesday said it has been awarded a development contract by The Small Business Research Initiative for Healthcare, an NHS England initiative, to cover phase 1 funding for the development of an online application designed to support dementia sufferers after they

Read more
16 Apr 2014 07:33

UK MORNING BRIEFING: RSA Loses UK & Western Europe Chief Executive

LONDON (Alliance News) - RSA Insurance Group said Wednesday the Chief Executive of the business which houses its troubled Irish operations has resigned in order to become Executive Chairman, underwriting and distribution, at business partner A J.Gallagher. The company said UK & Western Euro

Read more
20 Mar 2014 09:19

Thursday broker round-up UPDATE

Antofagasta: Deutsche Bank cuts target price from 770p to 735p and downgrades to sell. Investec cuts target price from 753p to 726p keeping its sell recommendation. Ashmore Group: HSBC Holdings lowers target price from 410p to 400p retaining its overweight rating. Avacta Group: Numis shifts target

Read more
11 Mar 2014 15:45

Standard Chartered non-exec builds company holding after profit decline

An Independent Non-Executive Director of Standard Chartered has this week upped his stake in the group by a quarter with the purchase of 2,500 shares. John Paynter, who was appointed to his role in 2008, bought the shares at 1,246.50p each for a total of £31,163, taking his total holding to 12,50

Read more
11 Mar 2014 15:07

DIRECTOR DEALINGS: Ixico Non-Executives Buy Shares

LONDON (Alliance News) - Ixico PLC said Tuesday that non-executive chairman Andy Richards had bought 13,700 shares at 78 pence each. Non-executive director Tim Sharpington bought 12,750 shares at 78.5 pence also on Tuesday. Following these purchases Richards has a 0.2% interest in the

Read more
7 Mar 2014 14:47

IXICO, VirtualScopics In International Commercial, Operational Alliance

LONDON (Alliance News) - Brain health company IXICO PLC Friday said it has entered into an international commercial and operational alliance with VirtualScopics Inc, a quantitative medical imaging provider. "The proposed alliance will provide the clinical trials industry with global operati

Read more
28 Feb 2014 15:59

IXICO Positive On Position Following Business Transition

LONDON (Alliance News) - IXICO PLC, the company formed when IXICO Ltd and Phytopharm PLC merged, said Friday that it believes it is strongly positioned in its core clinical trials and experimental medicine markets following the transition of its business. The company formally known as Phyto

Read more
18 Nov 2013 18:34

DIRECTOR DEALINGS: IXICO Non-Executive Director Buys Shares

Read more
18 Nov 2013 18:27

IXICO Non-Executive Director Buys Shares

Read more
1 Nov 2013 16:47

DIRECTOR DEALINGS: Ixico Executive Buys Shares

Read more
31 Oct 2013 14:05

DIRECTOR DEALINGS: IXICO CEO Buys 4,000 Shares

Read more
21 Oct 2013 12:45

DIRECTOR DEALINGS: IXICO Chairman Buys Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.